BioSpace News Archive

Drug Development

RAPT Therapeutics to Announce Initial Data from Phase 1/2 Clinical Trial of FLX475 in Multiple Cancer Indications

RAPT Therapeutics, Inc. announced that the Company plans to present initial data from its Phase 1/2 clinical trial of FLX475 in patients with multiple cancer indications in a premarket press release and webcast on Monday, November 16, 2020.

November 15, 2020
·
1 min read
Biotech Bay

Atara Biotherapeutics to Present New Open-Label Extension Data, Including 15-Month Safety and Efficacy Data from Highest Dose Cohorts, in the Phase1a Study of ATA188 for Progressive Forms of Multiple Sclerosis at the ECF 28th Annual Meeting

Long-term follow-up shows all patients who demonstrated sustained disability improvement (SDI) maintained it at all subsequent timepoints

November 15, 2020
·
8 min read
Drug Development

Arbutus Announces Presentation of Phase 1a/1b Clinical Trial Results for AB-729 in Chronic Hepatitis B Subjects at The Liver Meeting Digital Experience™, The American Association for the Study of Liver Diseases Meeting

Across all single-dose cohorts, mean HBsAg concentrations continuously declined up to week 12 before reaching a plateau, suggesting dosing of AB-729 less frequently than every 4 weeks may be warranted

November 15, 2020
·
7 min read
Biotech Bay

Mirum Pharmaceuticals Announces Data Presented During AASLD Highlighting Durable Improvements in Pruritus and Quality of Life in Children with Alagille Syndrome Treated with Maralixibat

Results of long-term treatment from the ITCH and IMAGINE II studies presented in late-breaking oral presentation at AASLD

November 15, 2020
·
9 min read
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China

Burning Rock Biotech Limited announced that it entered into a development and commercialization agreement with Myriad Genetics, Inc. which will bring myChoice® tumor testing for homologous recombination deficiency, or HRD, to China.

November 15, 2020
·
5 min read
CMIC Supports Clinical Trials for Digital Therapeutics Using SUSMED’s Trial Management System

CMIC Co., Ltd. has launched services using SUSMED, Inc.’s trial management system covering subject registration, software assignment and distribution for digital therapeutics.

November 15, 2020
·
4 min read
Immune Health Supplements Market | Advancements in Modern Medicine Drive the Market Growth

The global immune health supplements market is expected to grow at a sturdy pace in the years to follow.

November 15, 2020
·
3 min read
Obesity Management Market is likely to Expand at Decent Pace by 2029

Obesity refers to complicated health condition that involves increased body fats levels.

November 15, 2020
·
3 min read
Particle Size Analysis Market is expected to be mainly driven by the increasing focus on nanotechnology

The global particle size analysis market is expected to witness a strong growth in the coming years of the forecast period.

November 15, 2020
·
5 min read
PD L1 Biomarker Testing Market: Increasing prevalence of lung cancer across the globe to drive the market

The Covid-19 pandemic has had a profound effect on the overall development of the global PD L1 biomarker testing market.

November 15, 2020
·
4 min read